| Literature DB >> 28456467 |
Kathryn E Beckermann1, Stephanie O Dudzinski2, Jeffrey C Rathmell3.
Abstract
Metabolic and signaling pathways are integrated to determine T cell fate and function. As stimulated T cells gain distinct effector functions, specific metabolic programs and demands are also adopted. These changes are essential for T cell effector function, and alterations or dysregulation of metabolic pathways can modulate T cell function. One physiological setting that impacts T cell metabolism is the tumor microenvironment. The metabolism of cancer cells themselves can limit nutrients and accumulate waste products. In addition to the expression of inhibitory ligands that directly modify T cell physiology, T cell metabolism may be strongly inhibited in the tumor microenvironment. This suppression of T cell metabolism may inhibit effector T cell activity while promoting suppressive regulatory T cells, and act as a barrier to effective immunotherapies. A thorough understanding of the effect of the tumor microenvironment on the immune system will support the continued improvement of immune based therapies for cancer patients.Entities:
Keywords: Glycolysis; Immunotherapy; Mitochondria; Oxidative phosphorylation; T-cell
Mesh:
Year: 2017 PMID: 28456467 PMCID: PMC5710836 DOI: 10.1016/j.cytogfr.2017.04.003
Source DB: PubMed Journal: Cytokine Growth Factor Rev ISSN: 1359-6101 Impact factor: 7.638